Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

CCNG2 suppressor biological effects on thyroid cancer cell through promotion of CDK2 degradation.

Li WJ, Liu GL, Yu F, Xiang XX, Lu YF, Xiao HZ, Shi YP.

Asian Pac J Cancer Prev. 2013;14(10):6165-71.

2.

Decreased expression of CCNG2 is significantly linked to the malignant transformation of gastric carcinoma.

Sun GG, Hu WN, Cui DW, Zhang J.

Tumour Biol. 2014 Mar;35(3):2631-9. doi: 10.1007/s13277-013-1346-2. Epub 2013 Nov 19.

PMID:
24248541
3.

Changes in the expression of cyclin G2 in esophageal cancer cell and its significance.

Chen JQ, Liu CJ, Wen HX, Shi CL, Zhang HS, Li M, Sun GG.

Tumour Biol. 2014 Apr;35(4):3355-62. doi: 10.1007/s13277-013-1442-3. Epub 2013 Dec 3.

PMID:
24297335
4.

Change in expression of cyclin G2 in kidney cancer cell and its significance.

Cui DW, Sun GG, Cheng YJ.

Tumour Biol. 2014 Apr;35(4):3177-83. doi: 10.1007/s13277-013-1415-6. Epub 2013 Nov 23.

PMID:
24272084
5.

Effect of cyclin G2 on proliferative ability of prostate cancer PC-3 cell.

Cui DW, Cheng YJ, Jing SW, Sun GG.

Tumour Biol. 2014 Apr;35(4):3017-24. doi: 10.1007/s13277-013-1389-4. Epub 2013 Nov 29.

PMID:
24293374
6.

CCNG2 expression is downregulated in colorectal carcinoma and its clinical significance.

Sun GG, Zhang J, Hu WN.

Tumour Biol. 2014 Apr;35(4):3339-46. doi: 10.1007/s13277-013-1440-5. Epub 2013 Dec 3.

PMID:
24307622
7.

TRIM29 promotes progression of thyroid carcinoma via activating P13K/AKT signaling pathway.

Xu J, Li Z, Su Q, Zhao J, Ma J.

Oncol Rep. 2017 Mar;37(3):1555-1564. doi: 10.3892/or.2017.5364. Epub 2017 Jan 13.

PMID:
28098872
8.

An antiproliferative gene FLNA regulates migration and invasion of gastric carcinoma cell in vitro and its clinical significance.

Sun GG, Sheng SH, Jing SW, Hu WN.

Tumour Biol. 2014 Mar;35(3):2641-8. doi: 10.1007/s13277-013-1347-1. Epub 2013 Nov 16.

PMID:
24241900
9.

BTG1 expression in thyroid carcinoma: diagnostic indicator and prognostic marker.

Lu YF, Sun GG, Liu Q, Yang CR, Cheng YJ.

Int J Oncol. 2014 Oct;45(4):1574-82. doi: 10.3892/ijo.2014.2543. Epub 2014 Jul 11.

PMID:
25017022
10.

BTG1 underexpression is an independent prognostic marker in esophageal squamous cell carcinoma.

Sun GG, Wang YD, Cheng YJ, Hu WN.

Tumour Biol. 2014 Oct;35(10):9707-16. doi: 10.1007/s13277-014-2245-x. Epub 2014 Jun 27.

PMID:
24969561
11.

TPX2 overexpression in medullary thyroid carcinoma mediates TT cell proliferation.

Yang X, Liu G, Xiao H, Yu F, Xiang X, Lu Y, Li W, Liu X, Li S, Shi Y.

Pathol Oncol Res. 2014 Jul;20(3):641-8. doi: 10.1007/s12253-014-9743-4. Epub 2014 Feb 1.

PMID:
24488334
12.

Interactions between filamin A and MMP-9 regulate proliferation and invasion in renal cell carcinoma.

Sun GG, Wei CD, Jing SW, Hu WN.

Asian Pac J Cancer Prev. 2014;15(8):3789-95.

13.

MicroRNA-93 regulates cyclin G2 expression and plays an oncogenic role in laryngeal squamous cell carcinoma.

Xiao X, Zhou L, Cao P, Gong H, Zhang Y.

Int J Oncol. 2015 Jan;46(1):161-74. doi: 10.3892/ijo.2014.2704. Epub 2014 Oct 10.

PMID:
25309979
14.

PRDX1 and PRDX6 are repressed in papillary thyroid carcinomas via BRAF V600E-dependent and -independent mechanisms.

Nicolussi A, D'Inzeo S, Mincione G, Buffone A, Di Marcantonio MC, Cotellese R, Cichella A, Capalbo C, Di Gioia C, Nardi F, Giannini G, Coppa A.

Int J Oncol. 2014 Feb;44(2):548-56. doi: 10.3892/ijo.2013.2208. Epub 2013 Dec 5.

PMID:
24316730
15.

EMP1 inhibits nasopharyngeal cancer cell growth and metastasis through induction apoptosis and angiogenesis.

Sun GG, Lu YF, Fu ZZ, Cheng YJ, Hu WN.

Tumour Biol. 2014 Apr;35(4):3185-93. doi: 10.1007/s13277-013-1416-5. Epub 2013 Dec 1.

PMID:
24292952
16.

Differentiated thyroid carcinomas may elude the immune system by B7H1 upregulation.

Cunha LL, Marcello MA, Morari EC, Nonogaki S, Conte FF, Gerhard R, Soares FA, Vassallo J, Ward LS.

Endocr Relat Cancer. 2013 Feb 18;20(1):103-10. doi: 10.1530/ERC-12-0313. Print 2013 Feb.

17.

Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.

Huang Q, Fan J, Qian X, Lv Z, Zhang X, Han J, Wu F, Chen C, Du J, Guo M, Hu G, Jin Y.

J Cancer Res Clin Oncol. 2016 Jan;142(1):263-72. doi: 10.1007/s00432-015-2040-0. Epub 2015 Aug 30.

PMID:
26319393
18.

Expression of Wip1 in kidney carcinoma and its correlation with tumor metastasis and clinical significance.

Sun GG, Wang YD, Liu Q, Hu WN.

Pathol Oncol Res. 2015 Jan;21(1):219-24. doi: 10.1007/s12253-014-9811-9. Epub 2014 Jun 28.

PMID:
24970693
19.

Decreased expression of NPRL2 in renal cancer cells is associated with unfavourable pathological, proliferation and apoptotic features.

Tang Y, Jiang L, Tang W.

Pathol Oncol Res. 2014 Oct;20(4):829-37. doi: 10.1007/s12253-014-9761-2. Epub 2014 May 1.

PMID:
24789683
20.

BTG1 expression correlates with the pathogenesis and progression of breast carcinomas.

Sheng SH, Zhao CM, Sun GG.

Tumour Biol. 2014 Apr;35(4):3317-26. doi: 10.1007/s13277-013-1437-0. Epub 2013 Nov 24.

PMID:
24272202

Supplemental Content

Support Center